Rosiglitazone clinical trials
Also written Avandia.
How each study uses Rosiglitazone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Rosiglitazone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 25 May 1999 · AVANDIA · NDA 021071 (FDA, Drugs@FDA)
- European Union
- 11 Jul 2000 · Avandia · EMEA/H/C/000268 (EMA; now expired)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
142 studies that test it; most in 2006 (27)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 2 |
| 2000 | 7 |
| 2001 | 6 |
| 2002 | 10 |
| 2003 | 13 |
| 2004 | 17 |
| 2005 | 26 |
| 2006 | 27 |
| 2007 | 14 |
| 2008 | 11 |
| 2009 | 2 |
| 2010 | 3 |
| 2016 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 54 · Other 94
GlaxoSmithKline (41) · Novo Nordisk A/S (4) · University of Glasgow (3) · University of Washington (2) · James Lewis (2) · Stanford University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Massachusetts General Hospital (2)
Often tested with
Tested in the same studies.
Metformin (20) · Glyburide (3) · Flurbiprofen (3) · Glimepiride (3) · Fenofibrate (3) · Pioglitazone (3) · Ramipril (3) · Liraglutide (2)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Studies
Open first, then newest update. How each study uses Rosiglitazone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 148
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesRecruitingPhase 2Dan ZandbergNCT04114136Written as RosiglitazoneHow we know
- Rosiglitazone Adjunctive Therapy for Severe Malaria in ChildrenCompletedNot applicableCentro de Investigacao em Saude de ManhicaNCT02694874Written as RosiglitazoneHow we know
- Rosiglitazone in Treating Patients With LiposarcomaCompletedPhase 2Dana-Farber Cancer InstituteNCT00004180Written as rosiglitazone maleateHow we know
- A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo StudyCompletedPhase 3GlaxoSmithKlineNCT00432679Written as Rosiglitazone (BRL49653C)How we know
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-CompletedPhase 3GlaxoSmithKlineNCT00297063Written as RosiglitazoneHow we know
- Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary SyndromeCompletedNot applicableJean-Patrice BaillargeonNCT01019356Written as RosiglitazoneHow we know
- Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)CompletedPhase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00081328Written as RosiglitazoneHow we know
- Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's DiseaseCompletedPhase 2GlaxoSmithKlineNCT00265148Written as RosiglitazoneHow we know
- Rosiglitazone in Treating Patients With Pituitary TumorsTerminatedPhase 2Jonsson Comprehensive Cancer CenterNCT00616642Written as rosiglitazone maleateHow we know
- Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)TerminatedPhase 2Jonsson Comprehensive Cancer CenterNCT00612066Written as rosiglitazone maleateHow we know
- Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.CompletedPhase 2/3J JESUS VENEGAS, MDNCT04148183Written as Rosiglitazone groupHow we know
- Effect of RosiglitazoneCompletedNot applicableUniversity Hospital, MontpellierNCT00285142Written as rosiglitazoneHow we know
- Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00427154Written as rosiglitazoneHow we know
- Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DMCompletedNot applicableWashington University School of MedicineNCT00577590Written as RosiglitazoneHow we know
- Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone HealthCompletedPhase 4GlaxoSmithKlineNCT00679939Written as RosiglitazoneHow we know
- Preferred Treatment of Type 1.5 DiabetesCompletedNot applicableUniversity of WashingtonNCT00194896Written as rosiglitazoneHow we know
- Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedPhase 3GlaxoSmithKlineNCT00499707Written as rosiglitazone maleate/metformin hydrochlorideHow we know
- AVANDAMET Versus Metformin For Type 2 Diabetes MellitusCompletedPhase 4GlaxoSmithKlineNCT00241605Written as rosiglitazone/metforminHow we know
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedPhase 3GlaxoSmithKlineNCT00067951Written as rosiglitazone/metforminHow we know
- A Trial of Rosiglitazone for Ulcerative ColitisCompletedPhase 2James LewisNCT00065065Written as RosiglitazoneHow we know
See all 148 studies that test Rosiglitazone →
Given beside what is tested · 8 — Rosiglitazone is usual care or a partner of the new treatment
- Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes MellitusCompletedPhase 1Ohio State UniversityNCT00607945Written as Rosiglitazone (Avandia) OR other diabetes medication currently prescribed to participantHow we know
- BAY73-4506 Probe Substrate StudyCompletedPhase 1BayerNCT01287598Written as RosiglitazoneHow we know
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)CompletedPhase 3Merck Sharp & Dohme LLCNCT00350779Written as rosiglitazoneHow we know
- Rosiglitazone-Induced Weight GainTerminatedNot applicableStanford UniversityNCT00225225Written as RosiglitazoneHow we know
- A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneCompletedPhase 3AstraZenecaNCT00295633Written as rosiglitazoneHow we know
- A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy SubjectsCompletedPhase 1Vanda PharmaceuticalsNCT01402076Written as RosiglitazoneHow we know
- Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes PatientsCompletedPhase 3AstraZenecaNCT00680745Written as RosiglitazoneHow we know
- Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueCompletedNot applicableAristotle University Of ThessalonikiNCT00636766Written as rosiglitazoneHow we know
As the comparator · 5 — what is tested is compared with Rosiglitazone
- Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedPhase 3Novo Nordisk A/SNCT00343980Written as rosiglitazoneHow we know
- Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With MetforminCompletedPhase 3Daiichi SankyoNCT00484419Written as rosiglitazone maleateHow we know
- Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)CompletedPhase 3Merck Sharp & Dohme LLCNCT00541775Written as Comparator: RosiglitazoneHow we know
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedPhase 3TakedaNCT00331487Written as RosiglitazoneHow we know
- Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITerminatedPhase 3Solvay PharmaceuticalsNCT00361868Written as RosiglitazoneHow we know
Codes
What other systems call Rosiglitazone · ClinicalTrials.gg INT006654
- MeSH (NLM) D000077154RosiglitazoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 05V02F2KDGROSIGLITAZONEConfirmed FDA, NLM, Wikidata
- RxNorm 84108Confirmed FDA, Wikidata
- Wikidata Q424771(RS)-rosiglitazoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C62076RosiglitazoneOne source FDA
- DrugBank DB00412One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077154 | Rosiglitazone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 05V02F2KDG | ROSIGLITAZONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 84108 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424771 | (RS)-rosiglitazone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C62076 | Rosiglitazone | One source FDA |
| DrugBank | DB00412 | — | One source Wikidata |
Also registered as rosiglitazone maleate (UNII KX2339DP44 · RxNorm 253198).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.